NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment

Corporate Breaking News

Home : NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment

Apr 17 2018	NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment
LUND, Sweden, April 17, 2018 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South Korea Stock Market, KRX 003520) today announced that the last visit of the last healthy volunteer in the clinical phase I single...


Source:https://www.prnewswire.com/news-releases/neurovives-partner-yungjin-pharm-completes-kl1333-phase-i-study-recruitment-300631003.html

Related News
» The Polar Leasing Company to Showcase Outdoor Walk-in Coolers and Walk-in Freezers Rental Solutions at INTERPHEX 2018. » Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress